This site is intended for healthcare professionals only
LoginRegister
Marksans Pharma UK arm Relonchem gets marketing nod for high BP drugMarksans Pharma UK arm Relonchem gets marketing nod for high BP drug
Intas Pharma appoints Ajay Tiwari as President - HRIntas Pharma appoints Ajay Tiwari as President - HR
Shilpa Medicare bags initial authorization for Rotigotine Transdermal Patch from EuropeShilpa Medicare gets initial authorization from EMA for Rivaroxaban Orodispersible Films
Leadership Shift at Cipla: Umang Vohra to Exit, Achin Gupta Likely to Take Over as Global CEOLeadership Shift at Cipla: Umang Vohra to Exit, Achin Gupta Likely to Take Over as Global CEO
Dr Reddys Acquires Progynova, Cyclo-Progynova Brands from Mercury PharmaDr Reddy's Labs receives positive EMA Committee opinion for proposed biosimilar of Prolia, Xgeva
Sanofis Diabetes Drug Lantus SoloStar Insulin Batch Stolen, CDSCO Issues AlertSanofi Tolebrutinib faces USFDA review delay; new target action date set for December 28
CDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRelCDSCO Panel Flags Trial Death, Seeks Causality Report from Reliance Life Sciences on EtanerRel
Azithromycin, Ofloxacin Combos Among 3 Drug Batches Flagged as Purportedly Spurious by CDSCOSpurious Drugs Alert: Diazepam, PAN 40, and PAN-D Capsules Under Investigation
Cipla, Kemwell Ink Joint Venture Pact to Boost Global Biologics PlayCDSCO Panel Approves Cipla's Levormeloxifene Study Amendment, Mandates Transvaginal Sonography
Show cause notices issued to 196 retail medical shops in Telangana115 hospital pharmacies in Telangana receive show cause notices
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca-Amgen Tezspire recommended for approval in EU for chronic rhinosinusitis with nasal...
CII, ICON host strategic dialogue on Indian pharma move toward US manufacturingCII, ICON host strategic dialogue on Indian pharma move toward US manufacturing
X